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Background: Iodine 125 (125I) seed irradiation can be used as an important supplementary treatment for
unresectable advanced gastric cancer. Here, we aim to comprehensively elucidate the biological effects induced by
125I seed irradiation in human gastric cancer xenograft model by using global expression and DNA methylation
analyses.
Methods: The 48 mice bearing NCI-N87 gastric cancer xenografts were randomly separated into 2 groups: sham
seeds (O mCi) were implanted into the control group (n = 24); 125 l seeds (0.9 mCi) were implanted into the
treatment group (n = 24). The mitotic index and apoptotic index were evaluated by quantitative morphometric
analysis of the expression of proliferating cell nuclear antigen (PCNA) and in situ terminal transferase-mediated
fluorescein deoxy- UTP nick end labeling (TUNEL), respectively. Global gene expression changes induced by 125I
seed irradiation were analyzed by using Nimblegen Human gene expression array. DNA methylation profile in the
tumors from control group was investigated with methylated DNA immunoprecipitation (MeDIP) and Nimblegen
CpG promoter microarrays. The changes in the methylation status of selected genes were further investigated by
using MeDIP-PCR.
Results: 125I seed irradiation suppresses the growth of gastric cancer xenografts in nude mice. PCNA staining and
tissue TUNEL assays showed that both inhibition of cell proliferation and induction of apoptosis contribute to the
125I-induced tumor suppression in nude mouse model. Gene expression profiles revealed that the expression levels
of several hundred genes, many of which are associated with apoptosis or cell cycle arrest, including BMF, MAPK8,
BNIP3, RFWD3, CDKN2B and WNT9A, were upregulated following 125I seed irradiation. Furthermore, the up-
regulation of some of these genes, such as BNIP3 and WNT9A, was found to be associated with irradiation-induced
DNA demethylation.
Conclusions: This study revealed that 125I seed irradiation could significantly induce the up-regulation of
apoptosis- and cell cycle-related genes in human gastric cancer xenografts. And some of the up-regulation might
be attributed to 125I-irradiation induced demethylation in gene promoter regions. Collectively, these findings
provided evidence for the efficacy of this modality for the treatment of gastric cancer.* Correspondence: luokaiyuanyunnan@163.com
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Gastric cancer is one of the most frequent cancers in the
world, and almost of 50% gastric cancer death occurred
in China [1-3]. Surgery offers the only realistic chance of
cure; However, many of the patients present with unre-
sectable tumors at the time of diagnosis. Even with re-
section, still more than 50% of patients will relapse and
eventually die of their disease [4,5]. Therefore, non-
surgical methods have attracted increasing attention.
In recent years, 125I implantation has been widely
used to treat prostate cancer and other tumor types be-
cause of its ability to offer high precision, little trauma,
strong lethality, and fewer complications [6-9]. Most re-
cently, Wang and colleagues applied 125I implantation
to treat advanced gastric cancer and found significant
improvement in clinical symptoms and life quality of
patients [10].
Although the 125I seed implantation have been suc-
cessfully applied in clinic, its radiobiological effect and
underlying molecular mechanism are far from fully
understood. Recently, Zhuang and colleagues indicated
that continuous low dose rate irradiation influenced the
proliferation of cells via MAPK signal transduction. And
apoptosis was the main mechanism of cell-killing effects
under low dose rate 125I irradiation in CL187 cells [6].
Besides, Ma and colleagues demonstrated that 125I ir-
radiation significantly induced cell apoptosis and inhib-
ited DNMT1 and DNMT3b expression at 4 Gy in
pancreatic cancer cells. Thus, the irradiation-induced
apoptosis and DNA hypomethylation might be two key
mechanisms underlying the therapeutic effect of low en-
ergy 125I seed implantation [11]. However, to date, the
global molecular changes induced by 125I irradiation
have not yet been fully understood. In present study, we
profiled gene expression in human gastric cancer xeno-
grafts with microarrays to gain a comprehensive over-
view of changes induced by 125I seed irradiation.
Methods
Animal model
The human NCI-N87 cells (3x10 6/mouse) were sub-
cutaneously injected into right dorsal flank of each
BALB/c-nu/nu nude mouse. After 1–2 weeks of im-
plantation with tumor cells, when tumors reached ~20-
30 mm 3, the animals were randomized into control and
treatment groups (24 animals per group). The 125I seeds
(0.9 mCi) were injected into mice in treatment group
through 18-gauge needles, while ghost seed were
injected into the mice in control group.The tumor size
was measured using calipers and the tumor volume was
estimated by the formula: tumor volume (mm3) = (L x
W 2) × 1/2, where L is the length and W is the width of
the tumor. Tumor volumes and body weights were mon-
itored every 3 days over the course of treatment. Thetumor weight was measured when the mouse was sacri-
ficed. Mice were sacrificed after 28 days of treatments
and tumors were removed and fixed in 10% neutral buf-
fered formalin for histologic and immunohistochemical
analyses. All animal procedures were carried out with
the approval of the Animal Ethics Committee of Kunm-
ing Medical College.
Histological analysis of tumors
Tumors were embedded in paraffin, sectioned at 5 μm,
and stained with H&E (Sigma Aldrich, St. Louis, Mis-
souri, USA). The mitotic index and apoptotic index
were assessed by quantitative morphometric analysis of
proliferating cell nuclear antigen (PCNA) expression
and in situ terminal transferase-mediated fluorescein
deoxy-UTP nick end labeling (TUNEL), two established
markers of proliferation and apoptosis. For PCNA
localization, formalin-fixed, paraffin embedded sections
were incubated for 30 min with a mouse monoclonal
anti-PCNA (Nova Castra Laboratories, Newcastle Upon
Tyne, UK) at a 1:100 dilution. A peroxidase -conjugated
antibody to mouse IgG (Abcam Inc., Cambridge, MA,
USA) was applied followed by diaminobenzidine (Sigma
Aldrich,St. Louis, Missouri, USA) to localize PCNA in
the sections. DNA fragmentation was assessed by
TUNEL, using the Apoptag Peroxidase In situ Apop-
tosis Detection Kit (Serologicals Corp., Norcross, Ga,
USA). PCNA- or TUNEL-positive cells were quantified
in 40 randomly selected high-power fields (x 200) of
each tissue section.
RNA extraction
Total RNA was retracted from tumors using Trizol re-
agent (Life Technologies Inc., Gaithersburg, Maryland,
USA) according to manufacturer’s instructions. Total
RNA from each sample was quantified by the NanoDrop
ND-1000 (NanoDrop Technologies, Montchanin, DE,
USA) and RNA integrity was assessed by standard de-
naturing agarose gel electrophoresis. Total RNA from
one tumor from each mouse (6 tumors per group) was
used for qRT-PCR analysis, whereas total RNA from
tumors from four mice per group (12 tumors per group)
was pooled for each microarray hybridization.
Microarray analysis
Microarray analysis of whole-genome gene expression
profiling was performed using Human 12 x 135 K Gene
Expression Array (Roche Applied Science, Indianapolis,
IL, USA). Double-strand cDNA (ds-cDNA) was synthe-
sized from 5 μg of total RNA using a SuperScript
ds-cDNA synthesis kit (Life Technologies Inc., Gaithers-
burg, Maryland, USA) in the presence of 100 pmol oligo
dT primers. ds-cDNA was cleaned and labeled in ac-
cordance with the NimbleGen Gene Expression Analysis
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Microarrays were then hybridized with Cy3 labeled ds-
cDNA in a hybridization chamber (Roche Applied Sci-
ence, Indianapolis, IL, USA). After hybridization and
washing, the slides were scanned using the Axon Gene-
Pix 4000B microarray scanner (Axon Instruments,
Union City, CA, USA). Then, the data files were
imported into Agilent GeneSpring Software (Agilent
Technologies, Santa Clara, CA, USA) for analysis. Nim-
bleScan software’s implementation of robust multichip
average offers quantile normalization and background
correction. The six gene summary files were imported
into Agilent GeneSpring Software for further analysis.
Genes that have values greater than or equal to lower
cutoff of 50.0 in all samples were chosen for data ana-
lysis. The microarray experiment was independently
repeated in triplicate for each sample group. Differen-
tially expressed genes were identified through Fold-
change and T-test screening. GO analysis and Pathway
analysis were performed using the standard enrichment
computation method.
Real-time polymerase chain reaction (PCR)
DNase-treated total RNA extracted from each tumor
sample was reverse transcribed using the Transcriptor
1st Strand cDNA Synthesis Kit (Roche Diagnostics
GmbH, Mannheim, Germany). Real-time PCR was per-
formed for quantitative analysis using SYBR green dye
(TaKaRa, Tokyo, Japan) on the ABI-Prism 7900HT sys-
tem (Applied Biosystems, Foster City, CA, USA) accord-
ing to the protocols recommended by the manufacturer.
Cycling parameters: pre-denaturation 1 min, 95°C; de-
naturation 15 s, 95°C; annealing 15 s, 60 °C; extension
45 s, 72°C, 40 cycles; final extension 5 min, 70°C. The
fold change was calculated using the 2 -ΔΔCt method,
presented as the fold-expression change in irradiated
tumors relative to control tumors after normalization to
the endogenous control, GAPDH. All experiments were
carried out in triplicate technically. All primers are listed
in Additional file 1: Table S1.
Methyl-DNA immunoprecipitation and microarray
hybridization
Genomic DNA from tumors from six mice in the con-
trol group was pooled for Methyl-DNA immunopreci-
pitation (MeDIP) experiment. MeDIP was performed
as described previously [12]. Briefly, Genomic DNA
was sonicated to produce random fragments in size of
200–600 bp. Four micrograms of fragmented DNA was
used for a standard MeDIP assay as described. After
denaturation at 95°C for 10 min, immunoprecipitation
was performed using 10 μg monoclonal antibody
against 5-methylcytidine in a final volume of 500 μL IP
buffer (10 mmol/L sodium phosphate, pH 7.0),140 mmol/L NaCl, 0.05% Triton X-100) at 4°C for 2 h.
Immunoprecipitated complexes were collected with
Dynabeads Protein A and M-280 sheep anti-mouse IgG
(Roche Diagnostics GmbH, Mannheim, Germany) at
4°C for 12 h, washed with 1 × IP buffer for 4 times,
treated with Proteinase K at 50°C for 4 h, and purified
by phenol-chloroform extraction and isopropanol pre-
cipitation. Immunoprecipitated methylated DNA was
labeled with Cy5 fluorophere and the input genomic
DNA was labeled with Cy3 fluorophere. Labeled DNA
from the enriched and the input pools was combined
(1–2 μg) and hybridized to a NimbleGen HG18 CpG
promoter Array (Roche Diagnostics GmbH, Mannheim,
Germany), which contained all well-characterized
RefSeq promoter regions [from −800 bp to +200 bp
transcription start sites (TSSs)]. Array was then washed
and scanned with Axon GenePix 4000B microarray
scanner. After normalization, raw data was input into
SignalMap software (Roche Diagnostics GmbH, Mann-
heim, Germany) to observe and evaluate the methyla-
tion peaks. A customized peak-finding algorithm
provided by NimbleGen was applied to analyze methy-
lation data from MeDIP-microarray as previously
described. The algorithm was used to perform the
modified Kolmogorov-Smirnov test on several adjacent
probes using sliding windows to predict enriched
regions across the array.
MeDIP-quantitative PCR assay
A MeDIP assay, combined with qPCR, was used to
evaluate quantitatively the methylation status of candi-
date genes in the tumors derived from the control and
125I treatment groups. MeDIP was performed as
described above. Purified DNA from the immunopreci-
pitated DNA complexes and from input DNA was ana-
lyzed by qRT-PCR on an Applied Biosystems 7900
Real- Time PCR System. The experiment was per-
formed in triplicate. The relative changes in the extent
of gene methylation were determined by measuring the
amount of detected genes in immunoprecipitated DNA
after normalization to the input DNA. The primer
sequences are listed in Additional file 1: Table S1.
Statistical analysis
The results of the animal experiments and real-time
PCR were analyzed using SPSS 13.0 software. (SPSS Inc.,
Chicago, IL, USA) All data were plotted as mean ±
standard deviation. Student’s t-test was used to compare
values between two independent groups. Differences
were considered to be significance when p< 0.05.
Results
Inhibitory effect of I125 seed irradiation on the growth
of gastric cancer
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the growth of implanted NCI-N87 tumors was exam-
ined in nude mouse model. There were no significant
changes in the tumor volumes for the first 10 days of
the 125I seed treatment. However, after 13 days, the
125I-irradiated tumors were much smaller, and sig-
nificant differences in tumor volumes were observed
over time between the control and 125I treatment
groups (Figure 1A). At day 28, the mice were sacri-
ficed and tumor weights were measured. Statistical
difference in the tumor weight was observed between
the control and treatment groups (Figure 1B). All
these data clearly indicated that 125I seed implant-
ation could effectively inhibit tumor growth. Besides,
the body weights of mice were not affected by the
125I irradiation and no obvious radiation-induced
damage was observed in vital organs of mice (data
not shown), indicating the safety of 125I seed
treatment.Effect of 125I seed irradiation on tumor morphology of
gastric cancer
To investigate the effect of 125I irradiation on the hist-
ology of NCI-N87 xenografts, tumor sections taken
from mice in the control and 125I treatment groups
were stained with H&E. As shown in Figure 2, the
histologic appearance of tumors in the control group
was quite different from that in the 125I treatment
group. In the control group, the cancer cells were
densely arranged with large darkly-stained nuclei and
obvious karyokinesis. In the treatment group, large nec-
rotic regions were observed around the 125I seed. The
cancer cells adjacent to the necrotic region were loosely
arranged with condensed nuclei and reduced eosino-
philic cytoplasm. These results indicated that 125I seed
implantation caused growth inhibition of cancer cells in
NCI-N87 xenografts.Figure 1 Effect of 125I seed irradiation on the tumor volume and tum
mean± SD and analyzed by the Mann–Whitney U test (?: P< 0.05).Effect of 125I seed irradiation on cell apoptosis and
mitosis of gastric cancer
To quantitatively compare the mitotic and apoptotic
index of tumors treated with 125I seed irradiation,
immunostainings for PCNA and TUNEL assays were
performed. As shown in Figure 3A, the number of
PCNA- positive cells in the 125I treatment group was
obviously less than that of control group. And the mi-
totic index was significantly decreased in irradiated
tumors as compared to the tumors in the control group
(Figure 3B). In contrast to the mitotic index, 125I-
irradiated tumors showed increased numbers of apop-
totic cells with condensed and irregularly shaped nuclei,
staining positively for TUNEL (Figure 3C). the apoptotic
index was significantly increased in the 125I treatment
group as compared to the control group (Figure 3D).
Identification of genes induced by 125I seed irradiation
Gene expression microarrays were used to characterize
the gene expression changes in NCI-N87 tumors be-
tween the 125I treatment group and control group.
When the Fold Change (FC) is set> 1.3 and the
p value at ≤ 0. 05, we found that 544 genes were
induced by 125I seed irradiation, while 368 genes were
repressed (Additional file 2: Table S2). To identify the
biological processes that were induced by 125I seed ir-
radiation, Gene Ontology (GO) functional analysis was
performed. GO terms for biological processes were
assigned to these differential genes and this procedure
was essential to provide an overview of the effect of
125I seed implantation in NCI-N87 xenografts. Accord-
ing to GO functional analysis, the categories cell cycle,
induction of apoptosis, cell division and growth were
most significantly overrepresented among the 125-
irradiation induced genes (Additional file 3: Table S3).
And many of these genes are critical pro-apoptotic
molecules or genes associated with cell cycle arrest,
such as MAPK8, BNIP3 and CDKN2B (Table 1). Then,or weight. (A) Tumor volumes. (B) Tumor weight. Data are the
Figure 2 Pathology of 125 I implanted gastric cancer. Representative HE stained sections from the control and 125I treatment groups 28 d
after 125 I seed implantation were prepared as described in the Materials and Methods section.
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KEGG pathway map to further investigate key path-
ways linked to these genes. Our analysis yielded 11
pathways, including cell cycle pathway and several
pathways associated apoptosis and cell cycle arrest,
such as MAPK and TGF-beta signaling pathways
(Additional file 4: Table S4).
To independently confirm the microarray results, real-
time RT PCR was performed on samples from BALB/cFigure 3 PCNA and TUNEL analyses for tumor tissue. (A) Tumor section
were many strongly positive nuclei in control tumor tissues, whereas such
Quantification of PCNA staining showed mitotic index of 125I-implanted tu
Apoptosis of tumor tissues in different groups were evaluated by TUNEL as
enhancement of apoptotic cells in contrast to control group. (D) Quantifica
tumor was much higher than that of control group (?: P< 0.05).mice that had been exposed to the same experimental
conditions that were used in microarray assay. The rela-
tive expression levels of six genes—BMF, MAPK8,
BNIP3, RFWD3, CDKN2B and WNT9A—were assayed
in irradiated and non-irradiated tumors. There was a
close correlation between microarray data and qRT-PCR
data (Figure 4), indicating the accuracy of our micro-
array data and the significant induction in the expression
of selected genes following irradiation.s immunostained with an antibody against PCNA revealed that there
nuclei were rare in tumor tissues of 125I treatment group. (B)
mor was much lower than that of control group (?: P< 0.05). (C)
says, which showed that 125I treatment induced a significant
tion of TUNEL assay showed that apoptosis index of 125I-implanted
Table 1 125I-irradiation induced genes associated with apoptosis and cell cycle arrest
GENE_NAME DESCRIPTION Fold change P value FDR
Pro-apoptotic genes
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3 2.1 0.045 0.050
MAPK8 mitogen-activated protein kinase 8 1.7 0.017 0.047
BCL2L11 BCL2-like 11 (apoptosis facilitator) 1.9 5.39E-04 0.036
AKT1 v-akt murine thymoma viral oncogene homolog 1 1.4 0.028 0.049
BMF Bcl2 modifying factor 1.5 0.005 0.040
P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1.4 0.004 0.040
TNFRSF10B tumor necrosis factor receptor superfamily, member 10b 1.4 0.003 0.038
APH1A anterior pharynx defective 1 homolog A (C. elegans) 1.4 0.010 0.039
TRAIP TRAF interacting protein 1.4 0.032 0.046
JAK2 Janus kinase 2 (a protein tyrosine kinase) 1.6 0.011 0.045
TRIM35 tripartite motif-containing 35 1.3 0.018 0.046
ITSN1 intersectin 1 (SH3 domain protein) 1.5 0.020 0.046
TAP2 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) 1.3 0.024 0.048
ACVR1B activin A receptor, type IB 1.6 0.009 0.046
Genes associated with cell cycle arrest
CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 1.3 0.034 0.049
RFWD3 ring finger and WD repeat domain 3 1.3 0.040 0.050
HUS1 HUS1 checkpoint homolog (S. pombe) 1.4 0.017 0.047
PMP22 peripheral myelin protein 22 1.5 0.042 0.050
CDC25C cell division cycle 25 C 1.5 0.017 0.047
WNT9A wingless-type MMTV integration site family, member 9A 1.6 0.048 0.050
CCNG2 cyclin G2 1.5 0.003 0.038
CDC7 CDC7 cell division cycle 7 (S. cerevisiae) 1.4 0.016 0.049
C12orf32 chromosome 12 open reading frame 32 1.5 0.002 0.033
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molecules and pathways associated with apoptosis and
cell cycle arrest were activated by 125I seed irradiation
in NCI-N87 xenografts, thereby highlighting their im-
portant roles in 125I irradiation-induced inhibition of
tumor growth.
DNA methylation analysis of 125I-irradiation induced
genes
Aberrant DNA hypermethylation is commonly asso-
ciated with cancer. The Dnmt1 DNA methyltransferase
is responsible for maintenance of the DNA methylation
pattern. Consistent with previous study [11], significant
decrease of DNMT1 expression was observed in our
array data, and this result was validated via the real time
RT-PCR (Figure 5A). These data suggest that DNA
demethylation might be involved in 125I-induced tumor
suppression. Because promoter demethylation is asso-
ciated with gene re-activating, we focused our attention
on the 125I irradiation-induced genes by coupling globalgene expression and methylation profiles. The genes
with promoter hypermethylation in the non-irradiated
tumors were indentified with MeDIP-chip analysis (Add-
itional file 5: Table S5). Among them, we identified 20
genes whose expression was significantly upregulated in
the irradiated tumors as compared to the non-irradiated
tumors (Table 2). Thus, we speculated that the expres-
sion levels of these 20 genes might be modulated via the
promoter demethylation induced by 125I irradiation.
Notably, several of these genes were associated with
apoptosis or cell cycle arrest, such as BNIP3, WNT9A
and GSG2. To confirm our hypothesis, methylation sta-
tus of these three genes was examined with MeDIP-PCR
assay in the treatment and control groups. As shown,
BNIP3 and WNT9A in 125I treatment group displayed
lower levels of methylation status compared with control
group (P< 0.05), which decreased to 50.9% and 41.0%,
respectively (Figure 5B). Meanwhile, the expression
levels of BNIP3 and WNT9A were significantly upregu-
lated in the treatment group (Figure 5C). These data
Figure 4 Quantitative RT-PCR validation for differential genes
in microarrays. (A) Relative mRNA expression of 6 selected genes
in microarrays (B) Validation of relative mRNA expression of selected
genes with qRT-PCR. The significance of the varieties between the
control group (solid bar) and 125I treatment group (hollow bar) was
analyzed through student’s t-t test. (?: P< 0.05).
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genes could be activated by the demethylation of their
promoters, which were induced by 125I seed irradiation.
Discussion
Several recent studies have suggested that apoptosis and
cell cycle arrest may have important roles in the thera-
peutic effects of the continuous low-energy 125I irradi-
ation. However, the comprehensive evidences on this
topic, especially in molecular levels, still lack. In this
study, microarray analysis of human gastric cancer xeno-
grafts exposed to 125I seed irradiation were performed
to gain insight into the mechanisms underlying the bio-
logical effects of 125I irradiation.
N87 gastric cancer cells were implanted into the nude
mice to create the xenograft animal model. The growth
curves of tumors indicated that irradiation inducedsignificant tumor growth inhibition. By observing H.E.
staining slides, large numbers of apoptotic cells were
observed in gastric cancer receiving 125I seeds implant-
ation. Furthermore, the mitotic index and apoptotic
index were assessed by quantitative morphometric ana-
lysis of PCNA expression and TUNEL, respectively. In
our work, a declined mitotic index and increased apop-
totic index were discerned in 125I treatment group com-
pared with control group, which suggests that 125I seed
irradiation can restrain tumor growth and lead to apop-
tosis of cancer cells.
Next, we use microarray gene expression profile ana-
lysis to study the mechanism of irradiation-mediated
prevention of gastric tumors. To our knowledge, this is
the first investigation to use microarray technology to
study the role of 125I seed irradiation in cancer treat-
ment. At 28 days following 125I seed irradiation, the
nude mice were sacrificed and gene expression was pro-
filed in the xenografts by using gene expression microar-
rays. We found that the expression levels of 544 genes
were significantly induced by 125I seed irradiation.
Interestingly, among the irradiation-induced genes,
many are involved in cell cycle, apoptosis and cell div-
ision. The main pathways linked to these genes were
further investigated by KEGG analysis and several
apoptosis- or cell cycle-related pathways, such as MAPK
and TGF-beta pathways, were clearly indentified. Then,
the expression of 6 genes (BNIP3, MAPK8, BMF,
RFWD3, CDKN2B and WNT9A), which were asso-
ciated with apoptosis or cell cycle arrest, was further
validated via real time PCR analysis (Figure 3). BNIP3
(BCL2/adenovirus E1B 19 kDa interacting protein 3) is
a proapoptotic member of the Bcl-2 family and its mu-
tation and dysregulation might play a role in gastric car-
cinoma development [13]. Recent study revealed that
BNIP3 might play a role in enhancement of radiother-
apy efficiency, and its expression might have a synergis-
tic effect on radiation treatments [14]. MAPK8
(Mitogen-activated protein kinase 8) is a member of the
MAP kinase and JNK family. This gene is involved in
UV radiation-induced apoptosis, which is thought to be
related to the cytochrome c-mediated cell death path-
way [15]. BMF (Bcl-2-modifying factor) is a Bcl-2 family
member bearing only the BH3 domain and an essential
inducer of apoptosis [16]. BMF contributes to enhancing
effects on apoptosis after ionizing radiation [17].
RFWD3(ring finger and WD repeat domain 3) is an E3
ubiquitin ligase that positively regulates p53 levels and
regulates G1 Checkpoint in Response to ionizing radi-
ation [18]. CDKN2B (Cyclin-dependent kinase 4 inhibi-
tor B) belongs to a family of cyclin-dependent kinase 4
inhibitors (INK41) and controls cell proliferation during
the G1 phase of the cell cycle [19]. The expression of
this gene was found to be dramatically induced by TGF
Figure 5 Effects of 125I irradiation on gene methylation and mRNA expression in xenografts. (A) Relative expression of DNMT1 was
detected using qRT-PCR. (B) Effects of 125I irradiation on gene methylation of BNIP3 and WNT9A in xenografts assayed by MeDIP-PCR. BNIP3 and
WNT9A in treatment group displayed lower level of methylation when compared with control group. (C) Relative expression of BNIP3 and
WNT9A was detected using qRT-PCR. Data are expressed as the mean± SD of 6 samples. The significance of the varieties between the control
group and 125I treatment group was analyzed through student’s t-t test. (?: P< 0.05).
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growth inhibition [20]. WNT9A is a member of the
WNT gene family and over-expression of t human
Wnt9a induced cell-cycle arrest at G1/S boundary [21].
Consistent with previous study [11], we found signifi-
cantly decreased expression level of DNMT1 in theTable 2 The irradiation-induced genes with promoter hyperm
GENE_NAME DESCRIPTION
DRD5 dopamine receptor D5
PFN2 profilin 2
SKI v-ski sarcoma viral oncogene homolog (avian)
WNT9A wingless-type MMTV integration site family, member 9A
CXorf12 chromosome X open reading frame 12
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3
CHST10 carbohydrate sulfotransferase 10
PNMA1 paraneoplastic antigen MA1
C18orf55 chromosome 18 open reading frame 55
TRAK2 trafficking protein, kinesin binding 2
LRRC49 leucine rich repeat containing 49
EPB41L4B erythrocyte membrane protein band 4.1 like 4B
USP31 ubiquitin specific peptidase 31
GSG2 germ cell associated 2 (haspin)
ATAD1 ATPase family, AAA domain containing 1
MGC16385 hypothetical protein MGC16385
TCEB3C transcription elongation factor B polypeptide 3 C (elong
LONRF1 LON peptidase N-terminal domain and ring finger 1
SAMD11 sterile alpha motif domain containing 11
SLC35E2 solute carrier family 35, member E2irradiated xenografts. DNMT1 is responsible for precise
duplicating and maintaining the pre-existing DNA
methylation patterns after replication [22]. Therefore, it
is reasonable to speculate that DNA hypomethylation
induced by 125I irradiation might be associated with
tumor growth inhibition. By coupling data derived fromethylation in the non-irradiated tumors
Fold change Regulation P-value FDR
1.4 up 2.85E-04 0.03
1.4 up 0.021 0.05
1.6 up 0.005 0.04
1.6 up 0.048 0.05
2.0 up 0.012 0.05
2.0 up 0.045 0.05
2.2 up 0.010 0.05
1.3 up 0.001 0.04
1.4 up 0.009 0.05
1.3 up 0.047 0.05
1.5 up 0.041 0.05
1.4 up 0.027 0.05
1.5 up 0.021 0.05
1.6 up 0.035 0.05
1.3 up 0.006 0.04
1.4 up 0.046 0.05
in A3) 2.0 up 0.006 0.04
1.4 up 0.014 0.05
1.4 up 0.031 0.05
1.3 up 0.027 0.05
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we found 39 candidate genes whose expression might be
activated by 125I-induced DNA demethylation. Notably,
several of the candidates are pro-apoptotic molecules or
genes associated with cell cycle arrest, such as BNIP3,
WNT9A and GSG2 (Serine/threonine-protein kinase
haspin). The promoter demethylation of BNIP3 and
WNT9A after receiving 125I irradiation was then suc-
cessfully validated with MeDIP-PCR. DNA methylation
of the BNIP3 promoter was mediated by DNMT1 via
the MEK pathway [23]. Aberrant methylation of BNIP3
was also detected in 66% of primary colorectal and 49%
of primary gastric cancers. Epigenetic alteration of
BNIP3 is a frequent and cancer-specific event, which
suggests that inactivation of BNIP3 likely plays a key role
in the progression of some gastrointestinal cancers and
that it may be a useful molecular target for therapy [24].
Methylation of WNT9A promoter occurs frequently in
primary colon cancers and WNT9A hypermethylation in
cancer points to its possible role as a tumor suppressor
gene [25].
This study provides first demonstration for the global
induction of apoptotic and cell cycle-related genes by
125I seed irradiation. And some of the induction may be
mediated by the irradiation-induced DNA demethyla-
tion, suggesting that 125I seed irradiation affects genes
associated with apoptosis and cell cycle arrest in both
transcriptional and epigenetic levels. Collectively, these
data provide an explanation for the tumor inhibitory
effect of 125I seed implantation and emphasize the im-
portant roles of apoptosis and cell cycle arrest under-
lying the efficacy of this modality.
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